Disclaimer
The alfapump® system is currently not approved in Canada for commercial use. DSR® therapy is still in development and is currently not approved in the United States or Canada. Any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. Sequana Medical makes no claims of safety or effectiveness of the DSR® therapy in the U.S. or Canada. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe, the United States or Canada.
Chief Executive Officer
“Sequana Medical is at an exciting phase in its development with clear ambitions to accelerate its commercial growth and innovation. We continue to invest in our alfapump® and DSR® technologies to bring these innovative treatment options to a broader patient group and address important unmet medical needs, while creating value for shareholders.”
ISIN: XXXXXXXXXXXXX-XXXX Updated at 11:05:33
XXXXX.XX
For more information, please consult Euronext
September 19, 2024
